Drug Shortage Report for ACT NABILONE

Last updated on 2020-03-12 History
Report ID 101730
Drug Identification Number 02393603
Brand name ACT NABILONE
Common or Proper name NABILONE 1MG CAPSULES
Company Name ACTAVIS PHARMA COMPANY
Market Status MARKETED
Active Ingredient(s) NABILONE
Strength(s) 1MG
Dosage form(s) CAPSULE
Route of administration ORAL
Packaging size 50
ATC code A04AD
ATC description ANTIEMETICS AND ANTINAUSEANTS
Reason for shortage Other (Please describe in comments)
Anticipated start date 2019-10-01
Actual start date
Estimated end date
Actual end date 2019-10-31
Shortage status Resolved
Updated date 2020-03-12
Company comments Item is discontinued, transitioned to the TEVA DIN
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2020-03-12 French Compare
v5 2020-03-12 English Compare
v4 2019-12-19 French Compare
v3 2019-12-19 English Compare
v2 2019-12-19 French Compare
v1 2019-12-19 English Compare